| http://www.w3.org/ns/prov#value | - ???Among patients with type 2 diabetes, initiating DPP4i combination therapy may be associated with a decreased risk of rheumatoid arthritis or other autoimmune diseases compared to initiating non-DPP4i combination therapy,??? explains Dr. Kim. ???Although our results are not definitive, these results may contribute to the understanding of new mechanistic pathways for preventing or delaying the on
|
